-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F2Zps/6kARTC1OJNOjOGME9YMFpm8RhDyoS3n3jkMhPlLEaPATP7jh68E0MVlNvj 05tqFuW62hzvE2t+qQotjA== 0001033409-07-000014.txt : 20070418 0001033409-07-000014.hdr.sgml : 20070418 20070418124936 ACCESSION NUMBER: 0001033409-07-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070416 FILED AS OF DATE: 20070418 DATE AS OF CHANGE: 20070418 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 07772857 BUSINESS ADDRESS: BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 3151 17TH STREET EXTENSION CITY: WILMINGTON STATE: NC ZIP: 28412 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-04-16 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001033409 ESHELMAN FREDRIC N 6814 TOWLES ROAD WILMINGTON NC 28409 1 1 0 0 CEO Common Stock 2007-04-16 4 S 0 3200 34.69 D 8872160 D Common Stock 2007-04-16 4 S 0 100 34.71 D 8872060 D Common Stock 2007-04-16 4 S 0 200 34.72 D 8871860 D Common Stock 2007-04-16 4 S 0 746 34.73 D 8871114 D Common Stock 2007-04-16 4 S 0 3901 34.74 D 8867213 D Common Stock 2007-04-16 4 S 0 2453 34.75 D 8864760 D Common Stock 2007-04-16 4 S 0 800 34.76 D 8863960 D Common Stock 2007-04-16 4 S 0 200 34.78 D 8863760 D Common Stock 2007-04-16 4 S 0 2600 34.79 D 8861160 D Common Stock 2007-04-16 4 S 0 1800 34.80 D 8859360 D Common Stock 2007-04-16 4 S 0 2100 34.81 D 8857260 D Common Stock 2007-04-16 4 S 0 1100 34.82 D 8856160 D Common Stock 2007-04-16 4 S 0 1100 34.83 D 8855060 D Common Stock 2007-04-16 4 S 0 1900 34.84 D 8853160 D Common Stock 2007-04-16 4 S 0 1000 34.85 D 8852160 D Common Stock 2007-04-16 4 S 0 400 34.86 D 8851760 D Common Stock 2007-04-16 4 S 0 433 34.87 D 8851327 D Common Stock 2007-04-16 4 S 0 100 34.89 D 8851227 D Common Stock 2007-04-16 4 S 0 600 34.90 D 8850627 D Stock Options (to buy) 33.61 2008-02-21 2017-02-20 Common Stock 50000 50000 D Stock Options (to buy) 14.95 2005-12-03 2012-12-02 Common Stock 40000 40000 D Stock Options (to buy) 15.30 2004-12-03 2013-12-02 Common Stock 120000 120000 D Stock Options (to buy) 21.19 2005-11-16 2014-11-15 Common Stock 250000 250000 D Stock Options (to buy) 34.62 2007-02-22 2016-02-21 Common Stock 200000 200000 D The options were awarded on 12/3/03 and vest in three equal increments on 12/3/04, 12/3/05 and 12/3/06. The options were awarded on 11/16/04 and vest in four equal increments on 11/16/05, 11/16/06, 11/16/07 and 11/16/08. The options were awarded on 2/22/06 and vest in three equal increments on 2/22/07, 2/22/08 and 2/22/09. The options were awarded on 2/20/07 and vest as follows: 16,666 on 2/21/08, 16,667 on 2/21/09 and 16,667 on 2/21/10. This Form 4 is 3 of 3 Forms 4 being filed to report the sale of stock on April 16, 2007 pursuant to the 10b5-1 trading plan adopted by the Reporting Person. Lisa C. Noecker attorney-in-fact for Fred N. Eshelman 2007-04-18 -----END PRIVACY-ENHANCED MESSAGE-----